Skip to content

Gamma Medica-Ideas

  Gamma Medica-Ideas, a leader in digital imaging systems
Gamma Medica – Ideas (GM-I), Inc. has been in the business of designing, building, selling and servicing pre-clinical and clinical imaging systems since 2001.  We have the most multi-modality pre-clinical systems installed worldwide – on four continents – and we provide service to all of them.  GM-I boasts a well established skill set to manufacture highly complex systems.  Our pre-clinical experience lies in direct semiconductor and scintillation detection detectors, low noise ASIC electronics, and complex readout systems for PET, SPECT, and CT.  At the clinical level, our LumaGEM, a Molecular Breast Imaging (MBI) based system, revolutionizes the way breast cancer is diagnosed and treated.  A large part of GM-I’s focus is also directed towards research and development, concentrating our efforts on such fields as: radiation detector design, camera and systems engineering, ultra-low noise ASIC design, readout electronics, PET, SPECT and CT detectors.
Gamma Medica – Ideas (GM-I), Inc. has been in the business of designing, building, selling and servicing pre-clinical and clinical imaging systems since 2001.  We have the most multi-modality pre-clinical systems installed worldwide – on four continents – and we provide service to all of them.  GM-I boasts a well established skill set to manufacture highly complex systems.  Our pre-clinical experience lies in direct semiconductor and scintillation detection detectors, low noise ASIC electronics, and complex readout systems for PET, SPECT, and CT.  At the clinical level, our LumaGEM, a Molecular Breast Imaging (MBI) based system, revolutionizes the way breast cancer is diagnosed and treated.  A large part of GM-I’s focus is also directed towards research and development, concentrating our efforts on such fields as: radiation detector design, camera and systems engineering, ultra-low noise ASIC design, readout electronics, PET, SPECT and CT detectors.
Gamma Medica – Ideas (GM-I), Inc. has been in the business of designing, building, selling and servicing pre-clinical and clinical imaging systems since 2001.  We have the most multi-modality pre-clinical systems installed worldwide – on four continents – and we provide service to all of them.  GM-I boasts a well established skill set to manufacture highly complex systems.  Our pre-clinical experience lies in direct semiconductor and scintillation detection detectors, low noise ASIC electronics, and complex readout systems for PET, SPECT, and CT.  At the clinical level, our LumaGEM, a Molecular Breast Imaging (MBI) based system, revolutionizes the way breast cancer is diagnosed and treated.  A large part of GM-I’s focus is also directed towards research and development, concentrating our efforts on such fields as: radiation detector design, camera and systems engineering, ultra-low noise ASIC design, readout electronics, PET, SPECT and CT detectors.
Gamma Medica – Ideas (GM-I), Inc. has been in the business of designing, building, selling and servicing pre-clinical and clinical imaging systems since 2001.  We have the most multi-modality pre-clinical systems installed worldwide – on four continents – and we provide service to all of them.  GM-I boasts a well established skill set to manufacture highly complex systems.  Our pre-clinical experience lies in direct semiconductor and scintillation detection detectors, low noise ASIC electronics, and complex readout systems for PET, SPECT, and CT.  At the clinical level, our LumaGEM, a Molecular Breast Imaging (MBI) based system, revolutionizes the way breast cancer is diagnosed and treated.  A large part of GM-I’s focus is also directed towards research and development, concentrating our efforts on such fields as: radiation detector design, camera and systems engineering, ultra-low noise ASIC design, readout electronics, PET, SPECT and CT detectors.
Gamma Medica – Ideas (GM-I), Inc. has been in the business of designing, building, selling and servicing pre-clinical and clinical imaging systems since 2001.  We have the most multi-modality pre-clinical systems installed worldwide – on four continents – and we provide service to all of them.  GM-I boasts a well established skill set to manufacture highly complex systems.  Our pre-clinical experience lies in direct semiconductor and scintillation detection detectors, low noise ASIC electronics, and complex readout systems for PET, SPECT, and CT.  At the clinical level, our LumaGEM, a Molecular Breast Imaging (MBI) based system, revolutionizes the way breast cancer is diagnosed and treated.  A large part of GM-I’s focus is also directed towards research and development, concentrating our efforts on such fields as: radiation detector design, camera and systems engineering, ultra-low noise ASIC design, readout electronics, PET, SPECT and CT detectors.
Gamma Medica – Ideas (GM-I), Inc. has been in the business of designing, building, selling and servicing pre-clinical and clinical imaging systems since 2001.  We have the most multi-modality pre-clinical systems installed worldwide – on four continents – and we provide service to all of them.  GM-I boasts a well established skill set to manufacture highly complex systems.  Our pre-clinical experience lies in direct semiconductor and scintillation detection detectors, low noise ASIC electronics, and complex readout systems for PET, SPECT, and CT.  At the clinical level, our LumaGEM, a Molecular Breast Imaging (MBI) based system, revolutionizes the way breast cancer is diagnosed and treated.  A large part of GM-I’s focus is also directed towards research and development, concentrating our efforts on such fields as: radiation detector design, camera and systems engineering, ultra-low noise ASIC design, readout electronics, PET, SPECT and CT detectors.
Gamma Medica – Ideas (GM-I), Inc. has been in the business of designing, building, selling and servicing pre-clinical and clinical imaging systems since 2001.  We have the most multi-modality pre-clinical systems installed worldwide – on four continents – and we provide service to all of them.  GM-I boasts a well established skill set to manufacture highly complex systems.  Our pre-clinical experience lies in direct semiconductor and scintillation detection detectors, low noise ASIC electronics, and complex readout systems for PET, SPECT, and CT.  At the clinical level, our LumaGEM, a Molecular Breast Imaging (MBI) based system, revolutionizes the way breast cancer is diagnosed and treated.  A large part of GM-I’s focus is also directed towards research and development, concentrating our efforts on such fields as: radiation detector design, camera and systems engineering, ultra-low noise ASIC design, readout electronics, PET, SPECT and CT detectors.
 Home
Latest News
GM-I’s LumaGEM used for breast cancer detection at Mayo Clinic

An ongoing study at the Mayo Clinic in Rochester, MN, using GM-I’s LumaGEM, found a sensitivity of over 90% for lesions less than 20 mm, 88% for lesions less than 10 mm and 75% for lesions less than 5 mm.  This study demonstrated lesions as small as 3.3 mm.  This patient population included women who were positive on mammogram.  In a second study at Mayo in asymptomatic women with dense breasts and at high risk of breast cancer, preliminary results indicate that Molecular Breast Imaging may be able to detect significantly more tumors than screening mammography.
 
Gamma Medica-Ideas Announces Merger with Advanced Molecular Imaging

Gamma Medica-Ideas Announces Merger with Advanced Molecular Imaging
Gamma Medica-Ideas (GMI) has recently acquired Advanced Molecular Imaging (AMI) of Sherbrooke, Quebec, Canada, the only company in the world delivering a fully digital APD PET product for pre-clinical imaging.  AMI designs, manufactures and markets advanced imaging devices targeted at the pharmaceutical pre-clinical research and clinical diagnostic markets.  AMI holds a portfolio of proprietary technologies whose primary focus is in Positron Emission Tomography (PET) imaging based on the original, field-proven Avalanche PhotoDiode (APD) detector technology.  The LabPET™ is incredibly easy to use, as it integrates ancillary devices which are essential for performing reproducible and reliable molecular imaging studies.

The combined company thus emerges as the world’s first and only company with a complete range of digital imaging technologies including APD PET and GMI’s recently announced CZT SPECT detector technologies, as well as the most advanced range of multiple modality imaging systems for drug discovery and medical research.
 
Researchers at Gamma Medica are developing a simultaneous SPECT/MRI system

" SPECT/MRI shows great promise for opening up an entirely new medical imaging frontier. "
 — Dr. Bradley E. Patt, GM-I’s President and Chief Executive Officer

Until recently, a dual SPECT/MRI imaging system was all but impossible to construct because gamma cameras used in SPECT imaging contain vacuum tubes (a practice that dates from the 1950s), and signals from the cameras’ vacuum tubes are severely distorted by an MRI system’s magnetic field. However, GM-I recently introduced a new fully solid-state SPECT gamma camera that has no vacuum tubes. The GM-I gamma camera can be safely positioned within a magnet’s bore, enabling a combined SPECT/MRI imaging system to be designed.

MRI can acquire highly detailed anatomical images without the use of imaging contrast agents, and can enhance tumor visibility when used with contrast agents. SPECT, the most widely used nuclear medicine technique, employs a variety of radiopharmaceuticals to explore the molecular functions of cells and organs. GM-I and its collaborators plan to develop a dual-modality SPECT/MRI imaging instrument that will be able to acquire high-resolution, co-registered images by combining the functional information from SPECT with the anatomical information from MRI in a way that has never been done before.
 

Calendar of Events

September 2007 October 2007
Mo Tu We Th Fr Sa Su
Week 36 1 2
Week 37 3 4 5 6 7 8 9
Week 38 10 11 12 13 14 15 16
Week 39 17 18 19 20 21 22 23
Week 40 24 25 26 27 28 29 30

Upcoming Events

Press releases

See all Press Releases